SE413094B - Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur - Google Patents

Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur

Info

Publication number
SE413094B
SE413094B SE7501115A SE7501115A SE413094B SE 413094 B SE413094 B SE 413094B SE 7501115 A SE7501115 A SE 7501115A SE 7501115 A SE7501115 A SE 7501115A SE 413094 B SE413094 B SE 413094B
Authority
SE
Sweden
Prior art keywords
tyrosin
musculature
glossy
derivatives
preparation
Prior art date
Application number
SE7501115A
Other languages
English (en)
Other versions
SE7501115L (sv
Inventor
F Makovec
L Rovati
P Senin
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of SE7501115L publication Critical patent/SE7501115L/sv
Publication of SE413094B publication Critical patent/SE413094B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7501115A 1974-02-01 1975-01-31 Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur SE413094B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT67286/74A IT1062206B (it) 1974-02-01 1974-02-01 Derivati della tirosina attivi sulla muscolatura liscia

Publications (2)

Publication Number Publication Date
SE7501115L SE7501115L (sv) 1975-08-04
SE413094B true SE413094B (sv) 1980-04-14

Family

ID=11301149

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7501114A SE410850B (sv) 1974-02-01 1975-01-31 Forfarande for framstellning av d,l-tyrosinderivat med farmacentisk aktivitet pa glatt muskulatur
SE7501115A SE413094B (sv) 1974-02-01 1975-01-31 Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7501114A SE410850B (sv) 1974-02-01 1975-01-31 Forfarande for framstellning av d,l-tyrosinderivat med farmacentisk aktivitet pa glatt muskulatur

Country Status (19)

Country Link
US (1) US4004008A (sv)
JP (2) JPS5417728B2 (sv)
AT (2) AT342026B (sv)
BE (1) BE824995A (sv)
CA (2) CA1047498A (sv)
CH (2) CH605657A5 (sv)
DE (1) DE2503992C2 (sv)
ES (1) ES434323A1 (sv)
FI (2) FI61479C (sv)
FR (1) FR2259592B1 (sv)
GB (1) GB1467927A (sv)
HK (1) HK38979A (sv)
HU (2) HU174825B (sv)
IN (1) IN139364B (sv)
IT (1) IT1062206B (sv)
NL (1) NL167683C (sv)
NO (2) NO144210C (sv)
SE (2) SE410850B (sv)
ZA (1) ZA75530B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5225243A (en) * 1975-08-20 1977-02-25 Toshiba Electric Equip Corp Distributing panel
US4579866A (en) * 1984-05-29 1986-04-01 Usv Pharmaceutical Corp. Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
US5198458A (en) * 1986-02-04 1993-03-30 Suntory Limited Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5258407A (en) * 1991-12-31 1993-11-02 Sterling Winthrop Inc. 3,4-disubstituted phenols-immunomodulating agents
US5206373A (en) * 1992-02-28 1993-04-27 Merck & Co., Inc. Process for preparing fibrinogen receptor antagonists
DE10204951A1 (de) * 2002-02-06 2003-08-14 Basf Ag Phenylalaninderivate als Herbizide
EA200601105A1 (ru) * 2003-12-19 2006-12-29 Басф Акциенгезельшафт Замещённые бензоилом фенилаланин-амиды
BRPI0613423A2 (pt) * 2005-07-19 2012-12-11 Daiichi Sankyo Co Ltd composição farmacêutica, composto ou um seu sal farmaceuticamente aceitável, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
US8501982B2 (en) * 2010-06-09 2013-08-06 Receptos, Inc. GLP-1 receptor stabilizers and modulators
US9278910B2 (en) 2011-05-31 2016-03-08 Receptos, Inc. GLP-1 receptor stabilizers and modulators
JP6061949B2 (ja) 2011-12-12 2017-01-18 レセプトス エルエルシー 糖尿病などの疾患の治療のためのglp−1受容体モジュレーターとして作用する4つの環を含むカルボン酸誘導体
CN102659619A (zh) * 2012-04-18 2012-09-12 上海骏捷生化科技有限公司 一种合成酪氨酸衍生物的方法
CN103508920B (zh) * 2012-06-21 2016-03-02 贵州百灵企业集团制药股份有限公司 一种苯丙氨醇化合物的光学异构体的制备方法及其用途
CN103508921B (zh) * 2012-06-21 2015-09-30 贵州百灵企业集团制药股份有限公司 一种苯丙氨醇化合物的制备方法
EA030857B1 (ru) 2013-06-11 2018-10-31 Селджин Интернэшнл Ii Сарл Новые модуляторы рецептора glp-1
SG11201700364PA (en) 2014-07-25 2017-02-27 Celgene Internat Ii Sarl Novel glp-1 receptor modulators
EP3230276B1 (en) 2014-12-10 2020-09-02 Celgene International II Sarl Glp-1 receptor modulators
CN107417560B (zh) * 2017-03-30 2020-05-22 上海常丰生物医药科技有限公司 一种合成盐酸替罗酰胺的方法
CN110015978B (zh) * 2019-04-29 2021-03-19 康化(上海)新药研发有限公司 O-[2-[[叔丁氧羰基]氨基]乙基]-n-[芴甲氧羰基]-l-酪氨酸的合成方法
CN115850107A (zh) * 2022-11-30 2023-03-28 苏州诚和医药化学有限公司 一种工业化合成盐酸替罗酰胺的方法

Also Published As

Publication number Publication date
US4004008A (en) 1977-01-18
DE2503992A1 (de) 1975-08-14
NL7501193A (nl) 1975-08-05
JPS50116441A (sv) 1975-09-11
JPS50116442A (sv) 1975-09-11
HU174825B (hu) 1980-03-28
CA1047498A (en) 1979-01-30
HU175156B (hu) 1980-05-28
SE7501115L (sv) 1975-08-04
AU7775075A (en) 1976-08-05
NL167683C (nl) 1982-01-18
AT342026B (de) 1978-03-10
ES434323A1 (es) 1976-12-16
IT1062206B (it) 1983-09-20
FR2259592B1 (sv) 1978-07-21
FI63744C (fi) 1983-08-10
FI61479C (fi) 1982-08-10
NO144210B (no) 1981-04-06
NO750288L (sv) 1975-08-25
NL167683B (nl) 1981-08-17
NO144210C (no) 1981-07-15
IN139364B (sv) 1976-06-12
NO144211C (no) 1981-07-15
NO144211B (no) 1981-04-06
AT343632B (de) 1978-06-12
FI750256A (sv) 1975-08-02
ATA74575A (de) 1977-07-15
SE410850B (sv) 1979-11-12
CA1048503A (en) 1979-02-13
ATA74675A (de) 1977-10-15
NO750287L (sv) 1975-08-25
FI63744B (fi) 1983-04-29
CH605658A5 (sv) 1978-10-13
BE824995A (fr) 1975-05-15
JPS5417729B2 (sv) 1979-07-02
CH605657A5 (sv) 1978-10-13
DE2503992C2 (de) 1982-01-21
ZA75530B (en) 1976-01-28
GB1467927A (en) 1977-03-23
JPS5417728B2 (sv) 1979-07-02
SE7501114L (sv) 1975-08-04
FI750255A (sv) 1975-08-02
FI61479B (fi) 1982-04-30
FR2259592A1 (sv) 1975-08-29
HK38979A (en) 1979-06-22

Similar Documents

Publication Publication Date Title
SE413094B (sv) Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur
NO143218C (no) Analogifremgangsmaate til fremstilling av nonapeptidamider med lh-rh aktivitet
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
SE423544B (sv) Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE420598B (sv) Analogiforfarande for framstellning av naftalenderivat
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
SE7507564L (sv) Aluminiumhydridoligomerderivat samt forfarande for framstellning av desamma.
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO149775C (no) Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
NO147274C (no) Fremgangsmaate for fremstilling av n-metylerte urea-derivater
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat